Stay updated on Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T15:13:13.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T01:24:12.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding detailed descriptions of a clinical trial for nasopharyngeal cancer, including its objectives, methodology, and eligibility criteria. The revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    56%
    Check dated 2025-04-16T14:10:58.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and changed the date from March 25, 2025, to February 14, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T08:48:19.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:04:24.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:55:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.